Patents Examined by Nabila Ebrahim
-
Patent number: 8795712Abstract: A therapeutic device to release a therapeutic agent comprises a porous structure coupled to a container comprising a reservoir. The reservoir comprises a volume sized to release therapeutic amounts of the therapeutic agent for an extended time when coupled to the porous structure and implanted in the patient. The porous structure may comprise a first side coupled to the reservoir and a second side to couple to the patient to release the therapeutic agent. A plurality of interconnecting channels can extend from the first side to the second side so as to connect a first a plurality of openings on the first side with a second plurality of openings on the second side.Type: GrantFiled: May 7, 2013Date of Patent: August 5, 2014Assignee: ForSight Vision4, Inc.Inventors: Eugene de Juan, Jr., Yair Alster, Hanson S. Gifford, III, Michael Barrett, Randolph E. Campbell, Douglas Sutton
-
Patent number: 8795703Abstract: A stand-alone film is derived at least in part from fatty acids. The stand-alone film can have anti-adhesive, anti-inflammatory, non-inflammatory, and wound healing properties, and can additionally include one or more therapeutic agents incorporated therein. Corresponding methods of making the stand-alone film include molding, casting, or otherwise applying a liquid or gel to a substrate, and curing or otherwise treating to form the stand-alone film. The resulting stand-alone film is bioabsorbable.Type: GrantFiled: September 28, 2005Date of Patent: August 5, 2014Assignee: Atrium Medical CorporationInventors: Thomas M. Swanick, Joseph Ferraro, Paul Martakos, Lisa Rogers, Theodore Karwoski, Steve A. Herweck, Keith Faucher, Philip McNamara
-
Patent number: 8784790Abstract: Chronic wounds may be treated by debriding necrotic and other devitalized tissue from the wound, and applying to the wound an extracellular polymeric substance solvating system comprising a metal ion sequestering agent, surfactant and buffering agent. The solvating system disrupts biofilms which may be present in the wound and aids or enables the resumption of normal healing.Type: GrantFiled: June 11, 2009Date of Patent: July 22, 2014Assignee: Medtronic Xomed, Inc.Inventors: Matthew F. Myntti, Dana A. Oliver, James B. Hissong, Jennifer G. Medina
-
Patent number: 8778306Abstract: The present invention provides compositions, systems, kits, and methods for preparation prior to a colonoscopy or other gastrointestinal procedure. In particular, the present invention provides a colon lavage system comprising an aqueous portion and a solid portion.Type: GrantFiled: April 20, 2010Date of Patent: July 15, 2014Inventor: Dale R. Bachwich
-
Patent number: 8771740Abstract: Nanoparticles of a compound are produced by spraying a solution of the compound into a heated chamber. The resulting product comprises a free flowing mixture of nanoparticles of the compound.Type: GrantFiled: May 21, 2006Date of Patent: July 8, 2014Inventor: Nicholas J. Kerkhof
-
Patent number: 8771719Abstract: A method of producing a bone-polymer composite. The method comprises the steps of providing a plurality of bone particles, combining the bone particles with a polymer precursor, and polymerizing the polymer precursor.Type: GrantFiled: August 12, 2003Date of Patent: July 8, 2014Assignee: Warsaw Orthopedic, Inc.Inventors: Lawrence A. Shimp, John M. Winterbottom, Todd M. Boyce, David Knaack
-
Patent number: 8765176Abstract: A method of manufacturing a tablet containing coated granules comprising compressing the coated granules containing biologically active substance and having a temperature exceeding a room temperature, whereby the tablet can be prevented from rupture of a part of a coating film of the granules at the time of tablet compression.Type: GrantFiled: June 19, 2002Date of Patent: July 1, 2014Assignee: Takeda Pharmaceutical Campany LimitedInventors: Keiichi Yamamoto, Yoshio Mizukami, Daisuke Izutsu
-
Patent number: 8758833Abstract: The present invention relates to a cosmetic, nutraceutical or dermatological composition for treating or preventing acne, comprising a peptide and oside extract of Schizandra fruit and a suitable excipient. Preferably, the extract is obtained from Schizandra sphenanthera. The composition may also comprise at least one anti-acne agent selected from a sebum-regulating agent, an antibacterial and/or antifungal agent, a keratolytic agent and/or a keratoregulating agent, an astringent, an anti-inflammatory and/or anti-irritant, an antioxidant and/or a free-radical scavenger, a cicatrizing agent, an anti-ageing agent and a moisturizing agent. The invention also relates to a method for cosmetic treatment of acne, characterized in that a cosmetic composition according to the invention is applied to the affected areas of the skin, or in that the affected individual takes a nutraceutical composition according to the invention orally.Type: GrantFiled: July 27, 2010Date of Patent: June 24, 2014Assignee: Laboratoires ExpanscienceInventors: Sebastien Garnier, Dalale Naaimi, Caroline Baudouin
-
Patent number: 8740929Abstract: A spacing device for use in fenestrations of the paranasal sinus, the device including a sheath which forms a hollow body defining at least two apertures. The sheath includes at least one layer loaded with an active substance. The ratio q of the external diameter ra of the hollow body to the internal diameter ri of the hollow body is about 1.2 to 3.0.Type: GrantFiled: February 6, 2002Date of Patent: June 3, 2014Assignee: Acclarent, Inc.Inventors: Achim Gopferich, Werner Hosemann
-
Patent number: 8734768Abstract: Disclosed are animal litters, processes for preparing animal litters, and methods for removal of animal waste. The disclosed animal litters are made from ingredients including virgin germ and have a total fat content of about 0.5 to about 15 based on the weight of the litter. The litters are provided in the form of discrete plural particles which tend to agglomerate when wetted.Type: GrantFiled: May 9, 2011Date of Patent: May 27, 2014Assignee: Grain Processing CorporationInventors: Lin Wang, Katherine Lauren Gregory
-
Patent number: 8716203Abstract: Disclosed is a water-soluble colonoscopy lubricant essentially comprising Polyethylene Glycol 400; Propylene Glycol; and Glycerin. Distilled water may be added as needed to achieve a desired viscosity. Additional ingredients such as a preservative and a pH adjuster may also be added to the colonoscopy lubricant.Type: GrantFiled: October 18, 2009Date of Patent: May 6, 2014Inventor: Eli D Ehrenpreis
-
Patent number: 8715742Abstract: A method is provided for reducing weight in a subject by administering an effective amount of a composition comprising omega-3 polyunsaturated fatty acid (PUFA), at least one of L-arginine, L-ornithine, an L-arginine precursor and an L-ornithine precursor, and at least one of a nucleobase, a nucleoside and a nucleic acid. The method can also be used to treat obesity, hyperlipidemia, diabetes and/or hypertension and for improving diathesis, or treating adult disease or disposition to adult disease.Type: GrantFiled: April 16, 2010Date of Patent: May 6, 2014Assignee: BBK Bio CorporationInventor: Masafumi Koide
-
Patent number: 8703209Abstract: Improved nutraceutical compositions and methods for maintaining healthy calcium metabolism and maintenance of muscle mass. The compositions include a first component selected from the group consisting of a citrate anion, a bicarbonate anion and an acetate anion; a second component selected from the group consisting of a potassium cation, a magnesium cation, a calcium cation, and a sodium cation; and a third component selected from the group consisting of resveratrol, green tea extract, tumeric, basil, sage, thyme, ginger or ginger extract, oregano or oregano extract, rosemary or rosemary extract, hypericum perforatum, glycyrrhiza glabra, plantago lanceolata, quercetin, glycyrrhiza glabra, and gingko biloba. The compositions may be administered conventionally in tablets or capsules, as a dietary supplement, or be delivered in a food additive, food or beverage product, functional food, medical food, botanical drug, over-the-counter (OTC) drug, or any other category of product for human or animal consumption.Type: GrantFiled: March 23, 2005Date of Patent: April 22, 2014Inventor: Edward Larry McCleary
-
Patent number: 8703189Abstract: The present invention provides a medicinal composition that exhibits excellent storage stability and, even over long-term storage, little change in the release rate of the pharmacologically active substance contained therein. The medicinal composition of the invention prepared by dissolving or dispersing a pharmacologically active substance and a pH-independent water-insoluble polymer in a molten low-melting substance, and which can be prepared by spraying a liquid substance, obtained by dissolving or dispersing the pharmacologically active substance in a molten mixture comprising the low-melting substance and the pH-independent water-insoluble polymer, and then cooling the liquid substance.Type: GrantFiled: May 23, 2002Date of Patent: April 22, 2014Assignee: Otsuka Pharmaceutical Co., Ltd.Inventor: Yuso Tomohira
-
Patent number: 8697633Abstract: Embodiments of methods of treating atherosclerosis are described. In some embodiments an emulsifier is provided to achieve levels in the systemic circulation that are effective to solubilize atherosclerotic plaque, resulting in plaque regression. In some embodiments, levels of greater than 50 ?M are achieved; in some embodiments levels ranging from about 100 ?M to about 600 ?M are achieved; in some embodiments, levels ranging from about 100 ?M to about 300 ?M are achieved. Emulsifiers can include bile salts, saponins, and ionic, nonionic, and zwitterionic detergents, or salts, conjugates, hydrates, solvates, or polymorphs thereof. In some embodiments, a statin can be administered simultaneously or sequentially with an emulsifier.Type: GrantFiled: October 2, 2012Date of Patent: April 15, 2014Assignee: AtheroNova Operations, Inc.Inventors: Filiberto Zadini, Giorgio Zadini
-
Patent number: 8673372Abstract: A method of improving the appearance of a hyperpigmented spot may comprise the step of applying a composition comprising an effective amount of banyan tree serum fraction, lotus serum fraction, and clover serum fraction to a hyperpigmented spot on a skin surface, wherein the composition is applied for a period of time sufficient to improve the appearance of the hyperpigmented spot. The method may include the step of identifying a hyperpigmented spot on a facial skin surface. Other methods as disclosed include a method for improving the appearance of post-inflammatory hyperpigmentation.Type: GrantFiled: February 22, 2012Date of Patent: March 18, 2014Assignee: The Procter & Gamble CompanyInventors: Cheri Lynn Swanson, Leo Timothy Laughlin, II, Deborah Ruth Finlay
-
Patent number: 8652523Abstract: The invention concerns microcapsules with prolonged release of active principles with low solubility, consisting of a core containing the active principle and coated with a polymer layer which controls the release of the active principle. The aim is that said oral microcapsules containing hardly soluble active principles, should have a coating film of sufficient thickness to ensure controlled permeability and should be adapted to industrial reproduction. This is achieved by the inventive microcapsules of mean diameter less than 1000 microns, and whereof the coating film contains a film-forming polymer (P1) insoluble in gastrointestinal tract fluids, a water-soluble polymer (P2), a plasticizer (PL), and optionally a lubricating surfactant (TA).Type: GrantFiled: July 28, 2003Date of Patent: February 18, 2014Assignee: Flamel TechnologiesInventors: Florence Guimberteau, Catherine Castan, RĂ©mi Meyrueix
-
Patent number: 8642015Abstract: The present invention is directed to the treatment of infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue. More specifically, the present invention is directed to aerosols that are used to treat infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue, compositions from which the aerosols are generated and methods of generating the aerosols. In an aerosol aspect of the present invention, an aerosol for delivery to the sinus cavity of a patient is provided. The aerosol includes at least: a) one or more compounds selected from antibiotics, antifungals, leukotriene antagonists, anti-TNF compounds, antihistamines, steroidal antiinflammatories, mucolytics, estrogen, progesterone and related hormones; and, b) water. The compounds are present in the water at a concentration ranging from 0.Type: GrantFiled: November 26, 2012Date of Patent: February 4, 2014Assignee: Aerosol Science Laboratories, Inc.Inventors: Robert Scott Osbakken, Russell N. Reitz, John C. Tarrant
-
Patent number: 8632790Abstract: The invention relates to a skin care pad comprising exfoliating elements (4) which are distributed between at least one first fibrous layer (2) and a second fibrous layer (6), said second layer having a lower basis weight than the first fibrous layer. In this way, the inventive pad can be used daily, in order to exfoliate and massage the skin and to remove make-up.Type: GrantFiled: August 9, 2004Date of Patent: January 21, 2014Assignee: SCA Tissue FranceInventors: Philippe Gregoire, Bernard Louis Dit Picard
-
Patent number: 8623395Abstract: A therapeutic device to release a therapeutic agent comprises a porous structure coupled to a container comprising a reservoir. The reservoir comprises a volume sized to release therapeutic amounts of the therapeutic agent for an extended time when coupled to the porous structure and implanted in the patient. The porous structure may comprise a first side coupled to the reservoir and a second side to couple to the patient to release the therapeutic agent. The length of the channels extending from the first side to the second side may comprise an effective length greater than a distance across the porous structure from the first side to the second side. The therapeutic device may comprise a penetrable barrier to inject therapeutic agent into the device when implanted in the patient.Type: GrantFiled: August 5, 2011Date of Patent: January 7, 2014Assignee: ForSight Vision4, Inc.Inventors: Eugene de Juan, Jr., Yair Alster, Kathleen Cogan Farinas, K. Angela MacFarlane, Cary J. Reich, Randolph E. Campbell